Corrigendum: CXCL11-dependent induction of FOXP3-negative regulatory T cells suppresses autoimmune encephalomyelitis (Journal of Clinical Investigation (2014) 124:5 (2009-2022) DOI: 10.1172/JCI71951);CXCL11-dependent induction of FOXP3-negative regulatory T cells suppresses autoimmune encephalomyelitis

Journal of Clinical Investigation

Volumn 124, Issue 5, 2014, Pages 2009-2022

  Zohar, Yaniv ^a   Wildbaum, Gizi ^a   Novak, Rostislav ^a   Salzman, Andrew L ^b   Thelen, Marcus ^c   Alon, Ronen ^d   Barsheshet, Yiftah ^a   Karp, Christopher L ^e,f   Karin, Nathan ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b Radikal Therapeutics Inc   (United States)

^c INSTITUTE FOR RESEARCH IN BIOMEDICINE   (Switzerland)

^d WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^e CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^f BILL AND MELINDA GATES FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR3; CXCL11 CHEMOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 4; STAT1 PROTEIN; STAT4 PROTEIN; TRANSCRIPTION FACTOR FOXP3;

ADOPTIVE TRANSFER; ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BINDING AFFINITY; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PHENOTYPE; POLARIZATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REGULATORY T LYMPHOCYTE;

ANIMALS; CHEMOKINE CXCL11; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; IMMUNOGLOBULIN G; MICE; MICE, KNOCKOUT; RECEPTORS, CXCR3; RECOMBINANT FUSION PROTEINS; STAT TRANSCRIPTION FACTORS; T-LYMPHOCYTES, REGULATORY; TH1 CELLS;

EID: 84899749711     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI120358     Document Type: Erratum

References (69)

1. Miller SD, Karpus WJ, Davidson TS. Experimental autoimmune encephalomyelitis in the mouse. Curr Protoc Immunol. 2010;Chapter 15:Unit 15.1.
2. Steinman L. Multiple sclerosis: a two-stage disease. Nat Immunol. 2001;2(9):762-764.
3. Wekerle H, Kojima K, Lannes-Vieira J, Lassmann H, Linington C. Animal models for multiple sclerosis. Ann Neurol. 1994;36(suppl):S47-S53.
4. Raine CS. Multiple sclerosis: a pivotal role for the T cell in lesion development. Neuropathol Appl Neurobiol. 1991;17(4):265-274.
5. Luger D, et al. Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category. J Exp Med. 2008;205(4):799-810.
6. Bettelli E, Kuchroo VK. IL-12- and IL-23-induced T helper cell subsets: birds of the same feather flock together. J Exp Med. 2005;201(2):169-171.
7. Cua DJ, et al. Interleukin-23 rather than interleukin- 12 is the critical cytokine for autoimmune inflammation of the brain. Nature. 2003;421(6924):744- 748.
8. Steinman L. A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nat Med. 2007; 13(2):139-145.
9. Wildbaum G, Zohar Y, Karin N. Antigen-specific CD25- Foxp3- IFN-(high) CD4+ T cells restrain the development of experimental allergic encephalomyelitis by suppressing Th17. Am J Pathol. 2010;176(6):2764-2775.
10. Sakaguchi S. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol. 2005; 6(4):345-352.
11. Shevach EM. Mechanisms of foxp3+ T regulatory cell-mediated suppression. Immunity. 2009; 30(5):636-645.
12. Groux H, et al. A CD4+ T-cell subset inhibits antigen- specific T-cell responses and prevents colitis. Nature. 1997;389(6652):737-742.
13. Chen Y, Kuchroo VK, Inobe J, Hafler D, Weiner HL. Regulatory T-cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science. 1994;265(5176):1237-1240.
14. Zlotnic A, Yoshei O. Chemokines: A new clasification system and their role in immunity. Immunity. 2000;12(2):121-127.
15. Proudfoot AE. chemokine receptors: A multifaceted therapeutic targets. Nat Rev Immunol. 2002; 2(2):106-115.
16. Luster AD. Chemokines - chemotactic cytokines that mediate inflammation. N Engl J Med. 1998; 338(7):436-445.
17. Liu JJ, Horst R, Katritch V, Stevens RC, Wuthrich K. Biased signaling pathways in 2-adrenergic receptor characterized by 19F-NMR. Science. 2012; 335(6072):1106-1110.
18. Blattermann S, et al. A biased ligand for OXE-R uncouples G and G signaling within a heterotrimer. Nat Chem Biol. 2012;8(7):631-638.
19. Rajagopal S, et al. Arrestin- but not G proteinmediated signaling by the "decoy" receptor CXCR7. Proc Natl Acad Sci U S A. 2010;107(2):628-632.
20. Reiter E, Ahn S, Shukla AK, Lefkowitz RJ. Molecular mechanism of arrestin-biased agonism at seven- transmembrane receptors. Annu Rev Pharmacol Toxicol. 2012;52:179-197.
21. Zimmerman B, et al. Differential arrestindependent conformational signaling and cellular responses revealed by angiotensin analogs. Sci Signal. 2012;5(221):ra33.
22. Kantor R, Bakhanashvili M, Achiron A. A mutated CCR5 gene may have favorable prognostic implications in MS. Neurology. 2003;61(2):238-240.
23. Liu MT, Keirstead HS, Lane TE. Neutralization of the chemokine CXCL10 reduces inflammatory cell invasion and demyelination and improves neurological function in a viral model of multiple sclerosis. J Immunol. 2001;167(7):4091- 4097.
24. Liu MT, Armstrong D, Hamilton TA, Lane TE. Expression of Mig (monokine induced by interferon) is important in T lymphocyte recruitment and host defense following viral infection of the central nervous system. J Immunol. 2001; 166(3):1790-1795.
25. Ransohoff RM, Kivisakk P, Kidd G. Three or more routes for leukocyte migration into the central nervous system. Nat Rev Immunol. 2003;3(7):569-581.
26. Rottman JB, Slavin AJ, Silva R, Weiner HL, Gerard CG, Hancock WW. Leukocyte recruitment during onset of experimental allergic encephalomyelitis is CCR1 dependent. Eur J Immunol. 2000; 30(8):2372-2377.
27. Sorensen TL, et al. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J Clin Invest. 1999;103(6):807-815.
28. Balashov KE, Rottman JB, Weiner HL, Hancock WW. CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions. Proc Natl Acad Sci U S A. 1999;96(12):6873-6878.
29. Huang D, et al. Chemokines and chemokine receptors in inflammation of the nervous system: manifold roles and exquisite regulation. Immunol Rev. 2000;177:52-67.
30. Huang DR, Wang J, Kivisakk P, Rollins BJ, Ransohoff RM. Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis. J Exp Med. 2001;193(6):713-726.
31. Godiska R, Chantry D, Dietsch GN, Gray PW. Chemokine expression in murine experimental allergic encephalomyelitis. J Neuroimmunol. 1995; 58(2):167-176.
32. Izikson L, Klein RS, Charo IF, Weiner HL, Luster AD. Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2. J Exp Med. 2000;192(7):1075-1080.
33. Fife BT, et al. CXCL10 (IFN-/-inducible protein-10) control of encephalitogenic CD4+ T cell accumulation in the central nervous system during experimental autoimmune encephalomyelitis. J Immunol. 2001;166(12):7617-7624.
34. Fife BT, Paniagua MC, Lukacs NW, Kunkel SL, Karpus WJ. Selective CC chemokine receptor expression by central nervous system-infiltrating encephalitogenic T cells during experimental autoimmune encephalomyelitis. J Neurosci Res. 2001;66(4):705-714.
35. Karpus WJ, Lukacs NW, McRae BL, Strieter RM, Kunkel SL, Miller SD. An important role for the chemokine macrophage inflammatory protein-1 in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis. J Immunol. 1995;155(10):5003-5010.
36. Meiron M, Zohar Y, Anunu R, Wildbaum G, Karin N. CXCL12 (SDF-1) suppresses ongoing experimental autoimmune encephalomyelitis by selecting antigen-specific regulatory T cells. J Exp Med. 2008;205(11):2643-2655.
37. Qin S, et al. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J Clin Invest. 1998; 101(4):746-754.
38. Sallusto F, Lenig D, Mackay CR, Lanzavecchia A. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med. 1998;187(6):875-883.
39. Nakae S, Iwakura Y, Suto H, Galli SJ. Phenotypic differences between Th1 and Th17 cells and negative regulation of Th1 cell differentiation by IL-17. J Leukoc Biol. 2007;81(5):1258-1268.
40. Colvin RA, Campanella GS, Sun J, Luster AD. Intracellular domains of CXCR3 that mediate CXCL9, CXCL10, and CXCL11 function. J Biol Chem. 2004;279(29):30219-30227.
41. Colvin RA, Campanella GS, Manice LA, Luster AD. CXCR3 requires tyrosine sulfation for ligand binding and a second extracellular loop arginine residue for ligand-induced chemotaxis. Mol Cell Biol. 2006;26(15):5838-5849.
42. Wildbaum G, Netzer N, Karin N. Plasmid DNA encoding IFN-gamma-inducible protein 10 redirects antigen-specific T cell polarization and suppresses experimental autoimmune encephalomyelitis. J Immunol. 2002;168(11):5885-5892.
43. Salomon I, Netzer N, Wildbaum G, Schif-Zuck S, Maor G, Karin N. Targeting the function of IFN-/- inducible protein 10 suppresses ongoing adjuvant arthritis. J Immunol. 2002;169(5):2685-2693.
44. Sun J, Madan R, Karp CL, Braciale TJ. Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10. Nat Med. 2009;15(3):277-284.
45. Sierro F, et al. Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7. Proc Natl Acad Sci U S A. 2007;104(37):14759-14764.
46. Burns JM, et al. A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. J Exp Med. 2006; 203(9):2201-2213.
47. Hartmann TN, et al. A crosstalk between intracellular CXCR7 and CXCR4 involved in rapid CXCL12-triggered integrin activation but not in chemokine-triggered motility of human T lymphocytes and CD34+ cells. J Leukoc Biol. 2008;84(4):1130-1140.
48. Drury LJ, et al. Monomeric and dimeric CXCL12 inhibit metastasis through distinct CXCR4 interactions and signaling pathways. Proc Natl Acad Sci U S A. 2011;108(43):17655-17660.
49. Vila-Coro AJ, Rodriguez-Frade JM, Martin De Ana A, Moreno-Ortiz MC, Martinez AC, Mellado M. The chemokine SDF-1 triggers CXCR4 receptor dimerization and activates the JAK/STAT pathway. FASEB J. 1999;13(13):1699-1710.
50. Smit MJ, et al. CXCR3-mediated chemotaxis of human T cells is regulated by a Gi- and phospholipase C-dependent pathway and not via activation of MEK/p44/p42 MAPK nor Akt/PI-3 kinase. Blood. 2003;102(6):1959-1965.
51. Gagliani N, et al. Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells. Nat Med. 2013;19(6):739-746.
52. Apetoh L, et al. The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27. Nat Immunol. 2010;11(9):854-861.
53. Finck BK, Linsley PS, Wofsy D. Treatment of murine lupus with CTLA4Ig. Science. 1994; 265(5176):1225-1227.
54. Luttrell LM, et al. Arrestin-dependent formation of 2 adrenergic receptor-Src protein kinase complexes. Science. 1999;283(5402):655-661.
55. Samama P, Cotecchia S, Costa T, Lefkowitz RJ. A mutation-induced activated state of the 2- adrenergic receptor. Extending the ternary complex model. J Biol Chem. 1993;268(7):4625-4636.
56. Izhak L, et al. A novel recombinant fusion protein encoding a 20-amino acid residue of the third extracellular (E3) domain of CCR2 neutralizes the biological activity of CCL2. J Immunol. 2009; 183(1):732-739.
57. Sapir Y, Vitenshtein A, Barsheshet Y, Zohar Y, Wildbaum G, Karin N. A fusion protein encoding the second extracellular domain of CCR5 arrests chemokine-induced cosignaling and effectively suppresses ongoing experimental autoimmune encephalomyelitis. J Immunol. 2010;185(4):2589-2599.
58. Serbina NV, Pamer EG. Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2. Nat Immunol. 2006;7(3):311-317.
59. Liu L, et al. Severe disease, unaltered leukocyte migration, and reduced IFN- production in CXCR3-/- mice with experimental autoimmune encephalomyelitis. J Immunol. 2006;176(7):4399-4409.
60. Frigerio S, et al. Beta cells are responsible for CXCR3-mediated T-cell infiltration in insulitis. Nat Med. 2002;8(12):1414-1420.
61. Guo L, Hu-Li J, Paul WE. Probabilistic regulation of IL-4 production in Th2 cells: accessibility at the Il4 locus. Immunity. 2004;20(2):193-203.
62. Irannejad R, et al. Conformational biosensors reveal GPCR signalling from endosomes. Nature. 2013; 495(7442):534-538.
63. Lohse MJ, Calebiro D. Cell biology: receptor signals come in waves. Nature. 2013;495(7442):457-458.
64. Chaudhry A, et al. Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation. Immunity. 2011; 34(4):566-578.
65. Madan R, et al. Nonredundant roles for B cellderived IL-10 in immune counter-regulation. J Immunol. 2009;183(4):2312-2320.
66. McRae BL, Vanderlugt CL, Dal Canto MC, Miller SD. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis. J Exp Med. 1995;182(1):75-85.
67. Krutzik PO, Nolan GP. Intracellular phospho-protein staining techniques for flow cytometry: monitoring single cell signaling events. Cytometry A. 2003;55(2):61-70.
68. Carothers AM, Urlaub G, Mucha J, Grunberger D, Chasin LA. Point mutation analysis in a mammalian gene: rapid preparation of total RNA, PCR amplification of cDNA, and Taq sequencing by a novel method. Biotechniques. 1989;7(5):494-496.
69. Schif-Zuck S, et al. Targeted overexpression of IL-18 binding protein at the central nervous system overrides flexibility in functional polarization of antigenspecific Th2 cells. J Immunol. 2005;174(7):4307-4315.